Abstract:Mycobacterium tuberculosis can persist in an altered physiological state for many years after initial infection, and it may reactivate to cause active disease. An analogous persistent state, possibly consisting of several different subpopulations of bacteria, may arise during chemotherapy; this state is thought to be responsible for the prolonged period required for effective chemotherapy. Using two models of drug-induced persistence, we show that both microaerophilic stationary-phase M. tuberculosis treated w… Show more
“…Furthermore, the differential sensitivity of σ R -RNAP and σ HrdB -RNAP to Rif might have important implications for how M. tuberculosis responds to Rif treatment. Transcriptional activity has been detected in M. tuberculosis even following extensive treatment with Rif, including heat-induced expression of DnaK (Hu et al, 2000). It is known from other work that DnaK is controlled by the σ R homologue, σ H , in M. tuberculosis (Raman et al, 2001), which suggests that like σ R -RNAP, σ H -RNAP is resistant to Rif.…”
Section: Occurrence Of Rbpa In Pathogenic Actinomycetesmentioning
SummaryRbpA is an RNA polymerase-binding protein that occurs in the actinomycete family of bacteria and is regulated by the disulphide stress-response sigma factor, σ σ σ σ R , in Streptomyces coelicolor . Here we demonstrate that rbpA null mutants exhibit a slow-growth phenotype and are particularly sensitive to the transcription inhibitor rifampicin. Strikingly, transcription mapping experiments revealed that rbpA expression is induced upon exposure of S. coelicolor to rifampicin and that this, in part, involves an increase in the activity of σ σ σ σ R . In contrast, the ribosomal RNA operon promoter rrnDp3 , which is recognized by the vegetative sigma factor σ σ σ σ HrdB , was strongly inhibited by rifampicin. Reconstitution of RNAP from an rbpA null mutant with purified RbpA revealed that RbpA stimulates transcription from rrnDp3 , even in the presence of rifampicin. The data presented suggest that RbpA confers basal levels of rifampicin resistance and is a novel regulator of rRNA synthesis in S. coelicolor .
“…Furthermore, the differential sensitivity of σ R -RNAP and σ HrdB -RNAP to Rif might have important implications for how M. tuberculosis responds to Rif treatment. Transcriptional activity has been detected in M. tuberculosis even following extensive treatment with Rif, including heat-induced expression of DnaK (Hu et al, 2000). It is known from other work that DnaK is controlled by the σ R homologue, σ H , in M. tuberculosis (Raman et al, 2001), which suggests that like σ R -RNAP, σ H -RNAP is resistant to Rif.…”
Section: Occurrence Of Rbpa In Pathogenic Actinomycetesmentioning
SummaryRbpA is an RNA polymerase-binding protein that occurs in the actinomycete family of bacteria and is regulated by the disulphide stress-response sigma factor, σ σ σ σ R , in Streptomyces coelicolor . Here we demonstrate that rbpA null mutants exhibit a slow-growth phenotype and are particularly sensitive to the transcription inhibitor rifampicin. Strikingly, transcription mapping experiments revealed that rbpA expression is induced upon exposure of S. coelicolor to rifampicin and that this, in part, involves an increase in the activity of σ σ σ σ R . In contrast, the ribosomal RNA operon promoter rrnDp3 , which is recognized by the vegetative sigma factor σ σ σ σ HrdB , was strongly inhibited by rifampicin. Reconstitution of RNAP from an rbpA null mutant with purified RbpA revealed that RbpA stimulates transcription from rrnDp3 , even in the presence of rifampicin. The data presented suggest that RbpA confers basal levels of rifampicin resistance and is a novel regulator of rRNA synthesis in S. coelicolor .
“…Alternatively, nonreplicating cells may contain some unresolved FtsZ-associated structures. Recently it has been shown that dormant cultures of M. tuberculosis exhibit both transcriptional and metabolic activity (Hu et al, 2000). It is unknown whether such transcriptional activity extends to the ftsZ gene.…”
The ftsZ gene of Mycobacterium tuberculosis H37Rv has been characterized as the first step in determining the molecular events involved in the cell division process in mycobacteria. Western analysis revealed that intracellular levels of FtsZ are growth phase dependent in both M. tuberculosis and Mycobacterium smegmatis. Unregulated expression of M. tuberculosis ftsZ from constitutive hsp60 and dnaA promoters in M. tuberculosis hosts resulted in lethality whereas expression from only the hsp60 promoter was toxic in M. smegmatis hosts. Expression of ftsZ from the dnaA promoter in M. smegmatis resulted in "sixfold overproduction and the merodiploids exhibited slow growth, an increased tendency to clump and filament, and in some cases produced buds and branches. Many of the cells also contained abnormal and multiple septa.
“…Thus, noncolony-forming Mtb were phenotypically tolerant to combination chemotherapy, and their viability was demonstrated by their ability to cause relapse. More recent studies of cfu-negative organ samples from Mtb-infected mice treated with other drug regimens suggested the presence of DD Mtb by detection of Mtb mRNA transcripts (49) or demonstrated the presence of DD Mtb by recovery of Mtb in liquid medium supplemented with CF from log-phase Mtb (50). The ability to use non-agar-based culture methods to grow DD Mtb from mice (22) or human sputum (13,14) makes the term "nonculturable" inappropriate.…”
Mycobacterium tuberculosis (Mtb) encounters stresses during the pathogenesis and treatment of tuberculosis (TB) that can suppress replication of the bacteria and render them phenotypically tolerant to most available drugs. Where studied, the majority of Mtb in the sputum of most untreated subjects with active TB have been found to be nonreplicating by the criterion that they do not grow as colony-forming units (cfus) when plated on agar. However, these cells are viable because they grow when diluted in liquid media. A method for generating such "differentially detectable" (DD) Mtb in vitro would aid studies of the biology and drug susceptibility of this population, but lack of independent confirmation of reported methods has contributed to skepticism about their existence. Here, we identified confounding artifacts that, when avoided, allowed development of a reliable method of producing cultures of ≥90% DD Mtb in starved cells. We then characterized several drugs according to whether they contribute to the generation of DD Mtb or kill them. Of the agents tested, rifamycins led to DD Mtb generation, an effect lacking in a rifampin-resistant strain with a mutation in rpoB, which encodes the canonical rifampin target, the β subunit of RNA polymerase. In contrast, thioridazine did not generate DD Mtb from starved cells but killed those generated by rifampin.Mycobacterium tuberculosis | differentially detectable | phenotypic tolerance | rifampin | thioridazine
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.